{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:50:41Z","timestamp":1789098641034,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005874","name":"Universit\u00e0 degli Studi G. D'Annunzio Chieti Pescara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Autoimmune rheumatological diseases (ARDs) have historically represented an absolute or relative contraindication for radiotherapy (RT) due to increased RT-related toxicity and the potential exacerbation of rheumatologic disease. ARDs are more frequent in females (F:M 4:1). Breast cancer (BC) is the most common\u00a0malignancy, accounting alone for 31% of female cancers. This study compared acute and late cutaneous toxicity in ARDs and non-ARDs population undergoing adjuvant breast RT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of patients with BC and ARDs treated between 2013 and 2023 were retrospectively reviewed. The ARDs group was compared with a control group in a 1:2 ratio, homogeneous by age, type of treatment, RT total doses and fractionations, and target volumes\u2019 prescription. Acute and late toxicity were recorded using RTOG scales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 44 women with ARDs (median age 61\u00a0years) and 88 woman (median age 62\u00a0years) as control group. In ARDs group, the most used RT schedules were conventional fractionation (72.7%), while hypofractionation schedule (40\u201344\u00a0Gy) was administered in 12 patients (27.3%). In the control group, 64 patients (72.7%) received RT with conventional fractionation and 24 patients (27.3%) hypofractionation (40\u201344\u00a0Gy). Overall acute skin toxicity rate was 80.4% in the control group vs 86.4% in the ARDs group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.681). Specifically, G2 toxicity was 22.0% in the control group vs 31% in the ARDs group, while G3 acute toxicity was 2.3% in both groups. Overall late skin toxicity was 21.6% in the control group vs 27.3% in ARDs group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.067). Statistically significant difference was observed in late G2 toxicity with a 0% rate in the control group vs 6.8% in the experimental group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ARDs do not seem to represent an absolute or relative contraindication in BC RT in terms of acute and late cutaneous toxicity. Hypofractionated schedule showed less toxicities in both group and, particularly, in ARDs group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12282-025-01791-7","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:12:33Z","timestamp":1760368353000},"page":"178-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience"],"prefix":"10.1007","volume":"33","author":[{"given":"Giulia","family":"de Pasquale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Donatiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-620X","authenticated-orcid":false,"given":"Andrea","family":"D\u2019Aviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8.","journal-title":"Lancet"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13014-015-0568-4","volume":"10","author":"W Budach","year":"2015","unstructured":"Budach W, B\u00f6lke E, Kammers K, et al. Adjuvant radiation therapy of regional lymph nodes in breast cancer\u2014a meta-analysis of randomized trials\u2014an update. Radiat Oncol. 2015;10:258. https:\/\/doi.org\/10.1186\/s13014-015-0568-4.","journal-title":"Radiat Oncol"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","volume":"20","author":"IH Kunkler","year":"2008","unstructured":"Kunkler IH, Canney P, van Tienhoven G, et al. Elucidating the role of chest wall irradiation in \u201cintermediate-risk\u201d breast cancer: the MRC\/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol). 2008;20:31\u20134. https:\/\/doi.org\/10.1016\/j.clon.2007.10.004.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.radonc.2008.09.026","volume":"91","author":"NP Rowell","year":"2009","unstructured":"Rowell NP. Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review. Radiother Oncol. 2009;91:23\u201332. https:\/\/doi.org\/10.1016\/j.radonc.2008.09.026.","journal-title":"Radiother Oncol"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11:754\u201365. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.001.","journal-title":"Autoimmun Rev"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2:119\u201325. https:\/\/doi.org\/10.1016\/s1568-9972(03)00006-5.","journal-title":"Autoimmun Rev"},{"key":"1791_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0360-3016(89)90074-6","volume":"17","author":"R Fleck","year":"1989","unstructured":"Fleck R, McNeese MD, Ellerbroek NA, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17:829\u201333. https:\/\/doi.org\/10.1016\/0360-3016(89)90074-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1200\/JCO.1997.15.7.2728","volume":"15","author":"MM Morris","year":"1997","unstructured":"Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol. 1997;15:2728\u201335. https:\/\/doi.org\/10.1200\/JCO.1997.15.7.2728.","journal-title":"J Clin Oncol"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/1097-0142(19910801)68:3<502::aid-cncr2820680310>3.0.co;2-v","volume":"68","author":"JM Robertson","year":"1991","unstructured":"Robertson JM, Clarke DH, Pevzner MM, Matter RC. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer. 1991;68:502\u20138. https:\/\/doi.org\/10.1002\/1097-0142(19910801)68:3%3c502::aid-cncr2820680310%3e3.0.co;2-v.","journal-title":"Cancer"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1001\/jama.1991.03460240088033","volume":"265","author":"J Varga","year":"1991","unstructured":"Varga J, Haustein UF, Creech RH, et al. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA. 1991;265:3292\u20135.","journal-title":"JAMA"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2019.03.006","volume":"135","author":"D Lin","year":"2019","unstructured":"Lin D, Lehrer EJ, Rosenberg J, et al. Toxicity after radiotherapy in patients with historically accepted contraindications to treatment (CONTRAD): An international systematic review and meta-analysis. Radiother Oncol. 2019;135:147\u201352. https:\/\/doi.org\/10.1016\/j.radonc.2019.03.006.","journal-title":"Radiother Oncol"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00130404-200311000-00005","volume":"9","author":"C Phan","year":"2003","unstructured":"Phan C, Mindrum M, Silverman C, et al. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J. 2003;9:461\u20136. https:\/\/doi.org\/10.1097\/00130404-200311000-00005.","journal-title":"Cancer J"},{"issue":"1007","key":"1791_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1259\/bjr\/22373346","volume":"84","author":"M Teoh","year":"2011","unstructured":"Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84(1007):967\u201396. https:\/\/doi.org\/10.1259\/bjr\/22373346.","journal-title":"Br J Radiol"},{"key":"1791_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.01.047","author":"JM Purswani","year":"2021","unstructured":"Purswani JM, Oh C, Jaros B, et al. Breast conservation in women with autoimmune disease: the role of active autoimmune disease and hypofractionation on acute and late toxicity in a case-controlled series. Int J Radiat Oncol Biol Phys. 2021. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.047.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1791_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.34074","volume":"4","author":"SM Yoon","year":"2021","unstructured":"Yoon SM, Chu F-I, Ruan D, et al. Assessment of toxic effects associated with dose-fractionated radiotherapy among patients with cancer and comorbid collagen vascular disease. JAMA Netw Open. 2021;4:e2034074. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.34074.","journal-title":"JAMA Netw Open"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ijrobp.2021.08.006","volume":"111","author":"PM Shaikh","year":"2021","unstructured":"Shaikh PM, Singh SA, Alite F, et al. Radiation toxicity in patients with collagen vascular disease: a meta-analysis of case-control studies. Int J Radiat Oncol Biol Phys. 2021;111:1214\u201326. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.08.006.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"1791_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/BCTT.S471901","volume":"30","author":"Z Wu","year":"2024","unstructured":"Wu Z, Hou L, Li C, Li X, Li Y. Hypofractionated versus conventional postmastectomy irradiation for breast cancer: comparison of acute skin toxicity. Breast Cancer (Dove Med Press). 2024;30(16):423\u201332. https:\/\/doi.org\/10.2147\/BCTT.S471901.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"1791_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4438-7","volume":"166","author":"Y Dong","year":"2017","unstructured":"Dong Y, Li T, Churilla TM, et al. Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis. Breast Cancer Res Treat. 2017;166:787\u201391. https:\/\/doi.org\/10.1007\/s10549-017-4438-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1791_CR21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.26355\/eurrev_202102_24863","volume":"25","author":"F Fiorica","year":"2021","unstructured":"Fiorica F, Ciancio G, Giuliani J, Bonetti A, Berretta M, Guarneri C, et al. Radiotherapy in cancer and rheumathoid arthritis patients: cancer treatment or control of articular flares? We can achieve both. Eur Rev Med Pharmacol Sci. 2021;25(3):1548\u201356. https:\/\/doi.org\/10.26355\/eurrev_202102_24863.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10147-012-0377-9","volume":"18","author":"N Akkaya","year":"2013","unstructured":"Akkaya N, Atalay NS, Selcuk ST, et al. Frequency of fibromyalgia syndrome in breast cancer patients. Int J Clin Oncol. 2013;18:285\u201392. https:\/\/doi.org\/10.1007\/s10147-012-0377-9.","journal-title":"Int J Clin Oncol"},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2354.2008.00997","volume":"18","author":"S Eyigor","year":"2009","unstructured":"Eyigor S, Karapolat H, Korkmaz OK, et al. The frequency of fibromyalgia syndrome and quality of life in hospitalized cancer patients. Eur J Cancer Care (Engl). 2009;18:195\u2013201. https:\/\/doi.org\/10.1111\/j.1365-2354.2008.00997.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1791_CR24","first-page":"480","volume":"7","author":"AM Chen","year":"2001","unstructured":"Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J. 2001;7:480\u201391.","journal-title":"Cancer J"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/acr.23505","volume":"70","author":"DJ Shah","year":"2018","unstructured":"Shah DJ, Hirpara R, Poelman CL, et al. Impact of radiation therapy on scleroderma and cancer outcomes in scleroderma patients with breast cancer. Arthritis Care Res (Hoboken). 2018;70:1517\u201324. https:\/\/doi.org\/10.1002\/acr.23505.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/art.20912","volume":"53","author":"V Benk","year":"2005","unstructured":"Benk V, Al-Herz A, Gladman D, et al. Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer. Arthritis Rheum. 2005;53:67\u201372. https:\/\/doi.org\/10.1002\/art.20912.","journal-title":"Arthritis Rheum"},{"key":"1791_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/BCTT.S109763","volume":"9","author":"AJ Kole","year":"2017","unstructured":"Kole AJ, Kole L, Moran MS. Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer (Dove Med Press). 2017;9:313\u201323. https:\/\/doi.org\/10.2147\/BCTT.S109763.","journal-title":"Breast Cancer (Dove Med Press)"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-025-01791-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:03:23Z","timestamp":1768165403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-025-01791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s12282-025-01791-7","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The design and the result of our analysis have been reviewed and approved by the Departmental Scientific Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}}]}}